Dermatomyositis, for instance, has been indicated as a potential trigger of interstitial lung disease, especially in anti-MDA5 (anti-melanoma differentiation-associated gene 5) antibody-positive patients, which are at higher risk for developing interstitial lung disease (83). The gene discussed is IFIH1; the disease is dermatomyositis.